千例以上保留乳头乳房切除术中组织扩张器、即刻假体与自体组织乳房重建的结果比较
单中心回顾性分析2006年至2016年6月共1028例保留乳头乳房切除术,比较组织扩张器(533例,51.8%)、自体组织(263例,25.6%)和即刻假体(232例,22.6%)重建的结果。组织扩张器重建较自体组织有更多轻微蜂窝织炎(p=0.0002),但完全乳头坏死(p=0.0126)和主要皮瓣坏死(p<0.0001)更少;较即刻假体有更多轻微蜂窝织炎(p=0.0006),但完全乳头坏死(p=0.0005)及主要(p<0.0001)和轻微(p=0.0028)皮瓣坏死更少。三种技术均可安全用于保留乳头乳房切除术,但即刻假体和自体组织重建的并发症多于组织扩张器重建。
要点
- 组织扩张器重建较自体组织重建轻微蜂窝织炎更多,但完全乳头坏死和主要皮瓣坏死更少。
- 组织扩张器重建较即刻假体重建轻微蜂窝织炎更多,但完全乳头坏死及主要和轻微皮瓣坏死更少。
- 即刻假体重建较自体组织重建轻微蜂窝织炎、轻微皮瓣坏死和部分乳头坏死更多。
核心结论
- 组织扩张器、即刻假体和自体组织乳房重建技术均可安全用于保留乳头乳房切除术。
- 即刻假体和自体组织重建的并发症多于组织扩张器重建。
研究设计与样本
- 单中心回顾性研究,纳入2006年至2016年6月所有保留乳头乳房切除术患者,共1028例手术。
- 按重建方式分为组织扩张器组533例(51.8%)、自体组织组263例(25.6%)和即刻假体组232例(22.6%),比较人口学特征和结局。
主要发现
- 组织扩张器组较自体组织组轻微蜂窝织炎显著更多(p=0.0002),但完全乳头坏死(p=0.0126)和主要乳房切除皮瓣坏死(p<0.0001)显著更少。
- 组织扩张器组较即刻假体组轻微蜂窝织炎显著更多(p=0.0006),但完全乳头坏死(p=0.0005)及主要(p<0.0001)和轻微(p=0.0028)皮瓣坏死显著更少。
- 即刻假体组较自体组织组轻微蜂窝织炎(p=0.0051)、轻微皮瓣坏死(p=0.0425)和部分乳头坏死(p=0.0437)显著更多。
- 其余结局在三组间等效。
临床怎么用
- 保留乳头乳房切除术后可根据患者情况选择组织扩张器、即刻假体或自体组织重建,三者均可安全实施。
- 若关注皮瓣和乳头坏死风险,组织扩张器重建的完全乳头坏死和主要皮瓣坏死发生率低于自体组织和即刻假体重建。
- 若关注轻微蜂窝织炎风险,组织扩张器重建的轻微蜂窝织炎发生率高于自体组织和即刻假体重建。
局限性
- 单中心回顾性研究,证据等级为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nipple-sparing mastectomy permits complete preservation of the nipple-areola complex with excellent aesthetic results and with oncologic safety similar to that associated with traditional mastectomy techniques. However, outcomes have not been directly compared for tissue expander-, immediate implant-, and autologous tissue-based breast reconstruction after nipple-sparing mastectomy. METHODS: All patients undergoing nipple-sparing mastectomy from 2006 to June of 2016 were identified at a single institution. Demographics and outcomes were analyzed and compared among different types of breast reconstruction. RESULTS: A total of 1028 nipple-sparing mastectomies were performed. Of these, 533 (51.8 percent) were tissue expander-based, 263 (25.6 percent) were autologous tissue-based, and 232 (22.6 percent) were immediate implant-based reconstructions. Tissue expander-based reconstructions had significantly more minor cellulitis (p = 0.0002) but less complete nipple necrosis (p = 0.0126) and major mastectomy flap necrosis (p < 0.0001) compared with autologous tissue-based reconstructions. Compared to immediate implant-based reconstruction, tissue expander-based reconstructions had significantly more minor cellulitis (p = 0.0006) but less complete nipple necrosis (p = 0.0005) and major (p < 0.0001) and minor (p = 0.0028) mastectomy flap necrosis (p = 0.0059). Immediate implant-based reconstructions had significantly more minor cellulitis (p = 0.0051), minor mastectomy flap necrosis (p = 0.0425), and partial nipple necrosis (p = 0.0437) compared with autologous tissue-based reconstructions. Outcomes were otherwise equivalent among the three groups. CONCLUSIONS: Tissue expander, immediate implant, and autologous tissue breast reconstruction techniques may all be safely offered with nipple-sparing mastectomy. However, reconstructive complications appear to be greater with immediate implant- and autologous tissue-based techniques compared with tissue expander-based reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Frey JD, Choi M, Salibian AA, et al. Comparison of Outcomes with Tissue Expander, Immediate Implant, and Autologous Breast Reconstruction in Greater Than 1000 Nipple-Sparing Mastectomies. Plast Reconstr Surg. 2017. PMID: 28538548. doi:10.1097/PRS.0000000000003340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。